These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17041286)

  • 81. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
    Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
    Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 85. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 86. [Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)].
    Misdrahi D; Verdoux H; Llorca PM; Baylé FJ
    Encephale; 2004; 30(4):409-10. PubMed ID: 15597462
    [No Abstract]   [Full Text] [Related]  

  • 87. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria.
    Adewuya AO; Ola BA; Mosaku SK; Fatoye FO; Eegunranti AB
    Acta Psychiatr Scand; 2006 Mar; 113(3):207-11. PubMed ID: 16466404
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system.
    Dassa D; Boyer L; Benoit M; Bourcet S; Raymondet P; Bottai T
    Aust N Z J Psychiatry; 2010 Oct; 44(10):921-8. PubMed ID: 20932206
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Schizophr Res; 2013 Dec; 151(1-3):203-8. PubMed ID: 24183751
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 92. Medication adherence and significant others' support of consumers with schizophrenia in Australia.
    McCann TV; Lu S
    Nurs Health Sci; 2009 Sep; 11(3):228-34. PubMed ID: 19689630
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Adherence to therapy in multiple sclerosis and schizophrenia].
    Bussfeld P; Czekalla J
    Fortschr Neurol Psychiatr; 2010 Mar; 78(3):139-46. PubMed ID: 20213580
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Awareness of illness in schizophrenia and outpatient treatment adherence.
    Cuffel BJ; Alford J; Fischer EP; Owen RR
    J Nerv Ment Dis; 1996 Nov; 184(11):653-9. PubMed ID: 8955677
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Quality of life in schizophrenia: insight and subjective response to neuroleptics.
    Browne S; Garavan J; Gervin M; Roe M; Larkin C; O'Callaghan E
    J Nerv Ment Dis; 1998 Feb; 186(2):74-8. PubMed ID: 9484306
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
    Vassileva I; Milanova V; Asan T
    Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Insight and adherence to medication in chronic schizophrenics.
    Lin IF; Spiga R; Fortsch W
    J Clin Psychiatry; 1979 Oct; 40(10):430-2. PubMed ID: 489521
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Medicine taking decisions: schizophrenia in comparison to asthma and epilepsy.
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):163-72. PubMed ID: 15788033
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder.
    Quach PL; Mors O; Christensen TØ; Krarup G; Jørgensen P; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
    Early Interv Psychiatry; 2009 Feb; 3(1):66-74. PubMed ID: 21352177
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
    Bernardo M; Cañas F; Herrera B; García Dorado M
    Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.